The new pharmaceutical price list from July 2017 (see Section 5.2) is expected to lower both public and private costs. They identify key priorities and set out implementation plans. However, even though recent efforts have been made to include meaningful indicators to measure progress, regular monitoring and evaluation of implemented reforms is limited Also, few independent evaluations of health system performance have taken place. Life expectancy for men is more than 10 years lower than for women, the largest gender gap in the EU.